Strategic cooperation between ARTES Biotechnology and PAC
ARTES and PAC join forces
(PresseBox) - Artes and PAC join forces and combine their technologies and know-how.
ARTES Biotechnology specializes in recombinant protein production, process development in microbial expression systems and is a technology provider for pharmaceutical processes, while PAC (Peschek Analytic Consulting) is highly skilled in the field of protein analysis and quality control. Together with PAC, ARTES will now prospectively offer analysis of product quality control along side determination and quantification of by-products and/or process related residuals. The method analysis portfolio of PAC allows ARTES to offer method development and validation in accordance with GMP guidelines in the following analytical methods as HPLC-UV/DAD, Mass Spectrometry Ion Trap (LC-ESI/APCI MS/MS), Mass spectrometry Quadrupole (LC-ESI-MS), Gas Chromatography-Mass Spectrometry, Capillary Electrophoresis, Dynamic Light Scattering and Electron Microscopy.
ARTES Biotechnology GmbH ? www.artes-biotechnology.com
ARTES is a Germany-based biotechnology company, specializes in recombinant protein production, process development from microbial expression systems and technology transfer. ARTES offers generation of optimized production cell lines in proprietary yeast expression systems based on Hansenula polymorpha and vaccine development on virus like particle technology (VLP). In addition to genetic engineering, the company provides fermentation and downstream process development, analytical assay development and production cell line characterization. ARTES operates worldwide from its 850 sqm S1 facilities in Langenfeld. The company focuses on contract R&D for red and white biotechnology products.
ARTES Biotechnology GmbH ? www.artes-biotechnology.com
ARTES is a Germany-based biotechnology company, specializes in recombinant protein production, process development from microbial expression systems and technology transfer. ARTES offers generation of optimized production cell lines in proprietary yeast expression systems based on Hansenula polymorpha and vaccine development on virus like particle technology (VLP). In addition to genetic engineering, the company provides fermentation and downstream process development, analytical assay development and production cell line characterization. ARTES operates worldwide from its 850 sqm S1 facilities in Langenfeld. The company focuses on contract R&D for red and white biotechnology products.
Datum: 21.08.2012 - 14:53 Uhr
Sprache: Deutsch
News-ID 176353
Anzahl Zeichen: 1783
contact information:
Town:
Langenfeld
Kategorie:
Handcrafts
Diese Pressemitteilung wurde bisher 399 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Strategic cooperation between ARTES Biotechnology and PAC"
steht unter der journalistisch-redaktionellen Verantwortung von
ARTES Biotechnology GmbH (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
